Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic?

This publication has 24 references indexed in Scilit:

• Target-based drug discovery: is something wrong?
  Drug Discovery Today, 2005
• Are drugs discovered in the clinic or the laboratory?
  Drug Discovery Today: TARGETS, 2004
• Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
  Science, 2004
• Streamlining drug discovery: finding the right drug against the right target to treat the right disease.
  Drug Discovery Today, 2004
• Current and Emerging Nonsteroidal Anti-Inflammatory Therapies Targeting Specific Mechanisms in Asthma and Allergy
  Treatments in Respiratory Medicine, 2004
• Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry
  Current Opinion in Pharmacology, 2003
• Knockouts model the 100 best-selling drugs—will they model the next 100?
  Nature Reviews Drug Discovery, 2003
• Geneticists Knock Out Lasker Competition
  Science, 2001
• Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
  New England Journal of Medicine, 2001
• Eugenics and Individual Phenotypic Variation: To What Extent Is Biology a Predictive Science?
  Science in Context, 1998